天美传媒

ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 6413

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Academic Journals Database
  • 天美传媒 J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Scholarsteer
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Overcoming challenges in the analysis of Cannabis and derived products

Joint Event on 18th International Conference on World Analytical Chemistry & Mass Spectrometry & World HPLC, Separation Techniques & Pharmacovigilance

Rob O Brien

Supra Research and Development, Canada

Keynote: J Anal Bioanal Tech

DOI:

Abstract
The imminent legal Cannabis Sector is projected to be worth 6 to 20 billion dollars in Canada alone. The highly regulated nature of this sector demands rigorous quality control measures that require advanced analytical mass spectrometry and other techniques to ensure product safety. The nature of the Cannabis plant and its current status as an illegal and controlled narcotic in many countries, add a level of complexity to the development of analytical protocols. This talk will highlight some of the challenges facing this sector and some of the approaches to overcome these. Specifically, issues with potency testing, quantifying medicinal dose delivery, pesticide testing, development of Certified Reference Materials and the importance of ISO 17025 accreditation and international standard development will all be discussed.
Biography

Rob O'Brien, Ph.D., President and Chief Technology Officer, was a professor in Analytical Chemistry for over 13 years and has more than 25 years of experience in analytical chemistry. An expert in analytical instrumentation, he has set up a number of advanced analytical laboratories and has held an executive position in a number of commercial enterprises. Rob O'Brien possesses a track record of successful commercialization of intellectual property developed from academic research. During his academic career, Rob O'Brien secured over 3 million dollars in research grants and has developed an extensive network of research collaborators.

E-mail: r.ob@suprathc.ca

 

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top